TW201912177A - Taiwan clam shell extracting substance with whitening and anti-aging function and its extraction and separation method - Google Patents

Taiwan clam shell extracting substance with whitening and anti-aging function and its extraction and separation method Download PDF

Info

Publication number
TW201912177A
TW201912177A TW106128655A TW106128655A TW201912177A TW 201912177 A TW201912177 A TW 201912177A TW 106128655 A TW106128655 A TW 106128655A TW 106128655 A TW106128655 A TW 106128655A TW 201912177 A TW201912177 A TW 201912177A
Authority
TW
Taiwan
Prior art keywords
extract
extraction
alcohol
taiwan
quinoa
Prior art date
Application number
TW106128655A
Other languages
Chinese (zh)
Inventor
林煜翔
陳建霖
陳振義
Original Assignee
宋祖瑩
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 宋祖瑩 filed Critical 宋祖瑩
Priority to TW106128655A priority Critical patent/TW201912177A/en
Priority to CN201810340106.4A priority patent/CN109419830A/en
Publication of TW201912177A publication Critical patent/TW201912177A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Abstract

The present invention relates to an extraction method of Chenopodium formmosanum hull beneficial for whitening and anti-aging, in which a composition of the extract obtained by extraction and purification can be used in anti-oxidation, whitening or anti-aging application. The method includes the following steps: obtaining a Chenopodium formmosanum hull, and sequentially performing alcohol extraction, filtration and drying so as to produce a preliminary extract; and selectively performing a purification step and a separation step on the aforementioned preliminary extract to separate the components of different nature of the preliminary extract or to directly apply the extract to the product.

Description

具美白與抗老功能的台灣藜殼萃取區分物及其萃取方法Taiwan quinoa shell extract with whitening and anti-aging functions and its extraction method

本發明係為一種台灣藜殼萃取方法,尤指一種利用酒精萃取以得濃縮純化所得的台灣藜殼萃取物,後續可利用層析方式區分萃取物,透過施用於皮膚或食用該萃取物有助於美白及抗老化。The invention is a method for extracting Taiwan quinoa shell, especially a Taiwan quinoa shell extract obtained by using alcohol extraction for concentration and purification. The extract can be subsequently separated by chromatography, which can be helpful by applying to the skin or eating the extract. For whitening and anti-aging.

台灣藜(Chenopodium formmosanum),又稱為紅藜、赤藜、紫藜、彩虹米,為莧科藜亞科藜屬之台灣原生種植物,屬一年生草本植物,是台灣原住民耕作百年以上的傳統作物,生長特性為耐旱、耐高鹽,原住民傳統使用上,多將台灣藜的穀粒去殼後與稻米等雜糧共煮,料理成粽子、竹筒飯,或釀造小米酒之用。台灣藜植株可食用,其幼苗、嫩葉和花穗入菜,另於中草藥方面,台灣藜全株可入藥,具有去濕、清熱、解毒、止瀉及改善皮膚癢等功用。台灣藜富含極佳且全面的營養素、礦物質及多種抗氧化物,為營養豐富的食材,素有「穀類紅寶石」的美名。Chenopodium formmosanum, also known as red quinoa, red quinoa, purple quinoa, and rainbow rice, is a Taiwan native plant of the genus Chenopodium and subfamily Chenopodiaceae. It is an annual herb and is a Taiwanese aboriginal tradition for more than 100 years. The growth characteristics of crops are drought tolerance and high salt tolerance. Traditionally, the aborigines traditionally used hulled Taiwan quinoa grains and cooked them with rice and other miscellaneous grains to cook rice dumplings, bamboo rice, and rice wine. Taiwan quinoa plants are edible, and their seedlings, tender leaves and flower spikes are used in vegetables. In addition, in terms of Chinese herbal medicine, Taiwan quinoa plants can be used as medicines, which have functions of dehumidifying, clearing heat, detoxifying, stopping diarrhea and improving skin itching. Taiwan quinoa is rich in excellent and comprehensive nutrients, minerals and various antioxidants. It is a nutrient-rich food and is known as the "grain ruby".

台灣藜的機能性成分以黃酮、酚類及甜菜色素為主,皆具有抗氧化、抗發炎及抗癌等生理活性,台灣藜的植物性多酚類含量遠超過一般穀類,多酚類也具備有許多抗氧化的功效,可抗發炎、抑制動脈硬化及血栓症、降血壓、維持血管彈性、促進胰島素分泌、抑制癌細胞增生等,並能防止老化,維持肌膚彈性;台灣藜中豐富的類黃酮物質同樣有助於清除自由基、抗氧化,有助於避免軟化血管,可促進糖、脂代謝和胰島素分泌。The functional components of Chenopodium sibiricum are mainly flavonoids, phenols, and beet pigments, and they all have antioxidant, anti-inflammatory, and anti-cancer physiological activities. It has many anti-oxidant effects, can resist inflammation, inhibit arteriosclerosis and thrombosis, lower blood pressure, maintain vascular elasticity, promote insulin secretion, inhibit cancer cell proliferation, etc., and can prevent aging and maintain skin elasticity. Rich in quinoa in Taiwan Flavonoids also help to scavenge free radicals, prevent oxidation, help to soften blood vessels, and promote sugar, lipid metabolism and insulin secretion.

台灣藜的穀粒在採收後多會去除紅褐色的外殼,因台灣藜外殼含具微毒性的「皂素」,導致帶殼食用台灣藜會苦澀、口感差,不易加工食用,也使限制帶殼台灣藜有攝取量的限制,因此台灣藜殼食用上的利用十分受限,且過去研究發現台灣藜殼約占全種子之27%,將台灣藜殼去除將損失近三成農務產出,如何有效利用台灣藜殼成為重要待解決的課題。Most of the grains of Taiwan Chenopodium will remove the reddish-brown shell after harvesting. Because the Taiwan Chenopodium shell contains the slightly toxic "saponin", it will cause the Taiwanese Chenopodium to be eaten with a bitterness and poor taste. There are restrictions on the intake of Taiwan quinoa, so the use of Taiwan quinoa is very limited. In the past, it was found that Taiwan quinoa husk accounts for about 27% of the total seeds. Removing Taiwan quinoa husk will lose nearly 30% of agricultural output. How to effectively use Taiwan quinoa has become an important issue to be solved.

承上,台灣藜既為優良的雜糧食品,將可食用部位進行萃取利用實為浪費,若能單獨利用不可食的台灣藜外殼,將能更有效的利用資源,因此本發明利用台灣藜殼以酒精萃取的方式,純化出有助於皮膚美白、抗老化、抗皺的台灣藜殼萃取區分物。It is inherited that Taiwan quinoa is an excellent miscellaneous food product. It is a waste to extract and use edible parts. If the inedible Taiwan quinoa shell can be used alone, it will be able to use resources more effectively. Therefore, the present invention uses Taiwan quinoa shell to The method of alcohol extraction purifies the extract of Taiwan quinoa which helps skin whitening, anti-aging and anti-wrinkle.

皮膚為了保護皮膚不受到陽光中紫外線的傷害,皮膚中的黑色素細胞(melanocytes)會合成黑色素(melanin)以抵禦紫外線,避免紫外線對細胞及遺傳物質造成傷害。過去研究指出酪胺酸酶(tyrosinase)為調控黑色素生成之關鍵酵素,不僅參與黑色素生成過程中的許多反應,並且為催化反應中速率限制步驟的關鍵酵素,因此酪胺酸酶的含量可作為黑色素生成反應之指標。由於黑色素生成量增加會導致膚色黯沉,觀感上使人看起來缺乏精神,因此如何保養皮膚以減緩黑色素生成或使皮膚恢復白皙,便成為眾多消費者追求之方向。Skin In order to protect the skin from ultraviolet rays in the sun, melanocytes in the skin will synthesize melanin to resist ultraviolet rays and prevent ultraviolet rays from causing damage to cells and genetic material. Past research has pointed out that tyrosinase is a key enzyme that regulates melanin production, not only participates in many reactions in the process of melanin production, but also is a key enzyme that catalyzes the rate limiting step in the reaction. Therefore, the content of tyrosinase can be used as melanin Generate an indicator of the response. As the increase in melanin production will lead to dull skin tone and make people look lacking in spirit, how to maintain skin to slow down melanin production or restore fair skin has become the direction pursued by many consumers.

有許多用於粧品及醫藥的美白劑(如:對苯二酚及汞),使用後會造成皮膚色素異常的現象,如過敏反應、皮膚發紅、皮膚疹,變色,以及降低對細菌和真菌感染的皮膚抵抗能力等副作用,甚至會引起腎臟毒性,因此研究者不斷尋求具有安全、有效的天然物來開發為美白產品。經研究證實具有美白效果的天然物質例如麴酸(kojic acid)、鞣花酸(ellagic acid)和熊果素(arbutin)等等,上述三者皆屬酪胺酸酶抑制劑。雖然這些物質對於美白的確有顯著的功效,卻各有其使用上之限制,例如麴酸非常的不穩定容易被氧化而變色及引起皮膚過敏,且長期過量使用麴酸產品會導致細胞毒性且發生病變;此外,有些美白劑之作用係為直接破壞黑色素細胞,易造成細胞的毒殺性。因此,如何找出可用以抑制黑色素並且具有安全性之有效成分,便成為一重要課題。There are many whitening agents used in cosmetics and medicine (such as hydroquinone and mercury), which can cause abnormal skin pigmentation after use, such as allergic reactions, redness of the skin, skin rash, discoloration, and reduction of bacteria and fungi. Side effects such as the resistance of infected skin can even cause kidney toxicity, so researchers are constantly looking for safe and effective natural products to develop whitening products. Natural substances such as kojic acid, ellagic acid, and arbutin, which are confirmed to have whitening effects through research, are all tyrosinase inhibitors. Although these substances do have significant effects on whitening, they each have their use restrictions. For example, osmic acid is very unstable and easily oxidized to cause discoloration and skin irritation. And long-term excessive use of osmic acid products can cause cytotoxicity and occur. Lesions; in addition, the role of some whitening agents is to directly destroy melanocytes, which is likely to cause cell toxicity. Therefore, how to find effective ingredients that can suppress melanin and have safety has become an important issue.

老化是生理狀態隨時間進程惡化的現象,衰老是生物老化的過程。衰老的發生可從分子階層,如遺傳物質、蛋白質、脂質等分子的變化觀察到,這種分子損傷造成老年之許多疾病。事實上,生物體內有許多自我修復自由基傷害的機制,然而當修護速度不及自由基傷害速度時,受損的分子就容易累積,並進一步造成疾病,隨年齡漸長,而增加發生機率的症狀,包括皮膚老化、關節炎、癌症、阿茲海默氏症等。關於衰老,最普及的理論為「自由基理論」。該理論假設衰老由因身體內由稱為「自由基」之高活性分子引發之反應所導致之變化的積累而產生。目前廣泛認為由自由基誘發之變化為衰老及疾病發展之主要原因。正常的生理代謝過程中,自由基多源於生理上粒線體電子傳遞鏈(electron transport chain)、過氧化(peroxidase)、細胞色質P450(cytochrome P-450)等系統下產生,代謝產生能量提供生物運用;事實上,生物體內有許多自我修復自由基傷害的機制,以維持代謝上的平衡,然而當修護速度不及自由基傷害速度時,受損的分子就容易累積,並進一步造成老化或疾病。年齡漸長、代謝下降或受到異常環境影響,例如:紫外線、吸菸、空氣汙染,甚至心理壓力、生活不正常都可能使自由基的平衡天秤向衰老方向傾斜。Aging is a phenomenon in which the physiological state deteriorates over time, and aging is a process of biological aging. The occurrence of aging can be observed from changes in molecules such as genetic material, proteins, lipids and other molecules. This kind of molecular damage causes many diseases in old age. In fact, there are many self-repairing mechanisms of free radical damage in the body. However, when the repair speed is not as fast as the free radical damage, the damaged molecules will easily accumulate and further cause disease. As the age increases, the probability of occurrence increases. Symptoms, including skin aging, arthritis, cancer, Alzheimer's disease, etc. Regarding aging, the most popular theory is the "free radical theory". The theory assumes that aging results from the accumulation of changes in the body caused by reactions initiated by highly active molecules called "free radicals." It is now widely believed that changes induced by free radicals are the main cause of aging and disease development. During normal physiological metabolism, free radicals are mostly generated from the physiological upper mitochondrial electron transport chain, peroxidase, and cytochrome P-450, and energy is produced by metabolism. Provide biological applications; in fact, there are many self-repairing mechanisms for free radical damage in the body to maintain metabolic balance. However, when the repair speed is not as fast as the free radical damage, the damaged molecules will easily accumulate and further cause aging. Or disease. Increasing age, decreased metabolism, or affected by abnormal environments, such as ultraviolet rays, smoking, air pollution, and even psychological stress and abnormal life may tilt the balance scale of free radicals toward aging.

進一步說明,自由基對生物遺傳物質產生損害而增加基因突變機會,轉而增加癌症發病率。同樣的,自由基對脂質分子之損傷會導致低密度膽固醇(LDL)過度氧化而產生動脈斑塊,轉而可能引起動脈粥樣硬化及其他心血管疾病。此外,自由基可造成蛋白質分子損傷導致交互連結(cross linking)、澱粉狀蛋白形成及腦細胞變化,轉而會引起阿茲海默氏症或增加阿茲海默氏症之發病率。自由基對蛋白質分子之損傷亦會引起導致關節炎之組織結構變化及自體免疫病症以及影響皮膚功能及外觀之膠原蛋白、彈性纖維受損。因此如何抗氧化、降低體內自由基,達到預防疾病及延緩細胞老化為當代醫療保健生物科技的一大發展重點。It further illustrates that free radicals cause damage to biological genetic material and increase the chance of genetic mutation, which in turn increases the incidence of cancer. Similarly, the damage of free radicals to lipid molecules can lead to the over-oxidation of low-density cholesterol (LDL) to produce arterial plaques, which in turn may cause atherosclerosis and other cardiovascular diseases. In addition, free radicals can cause damage to protein molecules resulting in cross linking, amyloid formation, and changes in brain cells, which in turn can cause Alzheimer's disease or increase the incidence of Alzheimer's disease. Damage of free radicals to protein molecules can also cause changes in the tissue structure of arthritis and autoimmune disorders, as well as damage to collagen and elastic fibers that affect skin function and appearance. Therefore, how to prevent oxidation, reduce free radicals in the body, achieve disease prevention, and delay cell aging is a major development focus of contemporary medical biotechnology.

另一方面,醣化作用(Glycation)係指葡萄糖或果糖附著到蛋白質上,使醣化的蛋白質改變結構及性質,變得容易聚集及交錯聯結。醣化作用發生的部位隨機,一般認為自由基濃度高會造成較高的醣化機率會,目前研究認為蛋白質過度醣化產生的最終醣化蛋白(Advanced Glycation End-products,AGEs),與老化及部分疾病有密切關係。當身體內醣化作用產生太多最終醣化蛋白時,易導致各部位的不同病變,如眼睛可能容易疲勞、乾澀甚至提高白內障及視網膜病變的風險;醣化所產生的最終醣化蛋白也會堆積在血管壁上,並誘發體內自由基產生,加速動脈變硬、管壁變厚;當最終醣化蛋白蓄積於骨頭時,骨頭會變得脆弱,細胞新生機制受到抑制,加速骨質疏鬆的情況。另外,根據研究,阿茲海默症患者腦部的額葉裡的蛋白質,與健康的老人相比,最終醣化蛋白高達3倍以上,說明體內累積最終醣化蛋白對許多疾病都有相關性。Glycation, on the other hand, refers to the attachment of glucose or fructose to a protein, which changes the structure and properties of the glycosylated protein, making it easier to aggregate and cross-link. Saccharification occurs randomly, and it is generally believed that a high concentration of free radicals will cause a higher probability of saccharification. At present, it is believed that the final glycated proteins (Advanced Glycation End-products, AGEs) generated by excessive saccharification of proteins are closely related to aging and some diseases relationship. When glycosylation in the body produces too much final glycated protein, it is easy to cause different lesions in various parts, such as eyes may be easily fatigued, dry and even increase the risk of cataract and retinopathy; the final glycated protein produced by glycation will also accumulate on the vessel wall It induces the generation of free radicals in the body, accelerates the hardening of arteries, and the thickening of the tube wall. When the final glycated protein accumulates in the bones, the bones become fragile, the cell regeneration mechanism is inhibited, and the condition of osteoporosis is accelerated. In addition, according to research, the protein in the frontal lobe of the brain of Alzheimer's patients is more than three times the final glycated protein compared to healthy elderly, indicating that the accumulation of final glycated protein in the body is relevant for many diseases.

醣化作用發生於皮膚真皮層的蛋白質上被視為皮膚老化、鬆弛的重要機制之一。膠原蛋白(Collagen)是人體一種重要的蛋白質,大約占蛋白質總量的25~35%,主要存在結締組織中,是細胞間的支架,具有很強的伸張能力,廣泛存在皮膚、角膜、關節、軟骨等組織中。尤其在皮膚中,膠原蛋白為主要支持的蛋白質,保持皮膚緊緻飽滿。而膠原蛋白的醣化,會使膠原蛋白纖維化而變得僵硬,皮膚失去填充,加速皮膚皺紋的產生。Glycation occurs on proteins in the dermal layer of the skin and is considered to be one of the important mechanisms for skin aging and relaxation. Collagen (Collagen) is an important protein in the human body, accounting for about 25 to 35% of the total protein. It is mainly present in connective tissue, is a scaffold between cells, has a strong ability to stretch, and is widely present in skin, cornea, joints, Cartilage and other tissues. Especially in the skin, collagen is the main supporting protein, keeping the skin firm and plump. The saccharification of collagen will make the collagen fibrosis and become stiff, the skin will lose its filling and accelerate the generation of skin wrinkles.

此外,彈性蛋白 (Elastin) 是一種構成彈性纖維的蛋白質,其廣泛分布在生物體內的各個組織和臟器中,主要存在於皮膚、韌帶、血管、肺、皮膚等有彈性的組織中。而這類組織不僅需要彈性,同時拉伸強度也是必不可少的,而且彈性蛋白對形態的構成和維持發揮重要的作用。彈性蛋白亦為皮膚組成的重要成分,彈性蛋白在皮膚中僅含5%,卻是產生彈性纖維及支撐膠原蛋白的關鍵。彈性蛋白分子能任意捲曲,在外力牽拉下,捲曲的彈性蛋白分子伸展拉長,除去外力後,彈性蛋白分子又回復為捲曲狀態,就像彈簧。人體彈性蛋白主要在胚胎晚期至新生兒早期合成,成人階段幾乎不再有新的彈性蛋白產生。占皮膚70%的膠原蛋白決定皮膚的柔潤飽滿,彈性纖維則決定皮膚的緊緻彈力。同樣的醣化和光老化過程(photoaging)也會導致彈性纖維也會產生質變,而失去原有彈性。彈性蛋白酶(Elastase)是一種可以讓結締組織中的彈力蛋白分解的酵素,彈力蛋白的減少會導致皺紋及下垂等老化徵兆。因此如何降低彈性蛋白的減少與破壞,是抗老化、抗皺、維持皮膚健康緊緻,是值得關注的議題。In addition, elastin (Elastin) is a protein constituting elastic fibers, which is widely distributed in various tissues and organs in the body, mainly in elastic tissues such as skin, ligaments, blood vessels, lungs, and skin. Not only does this type of tissue require elasticity, but tensile strength is also essential, and elastin plays an important role in morphological composition and maintenance. Elastin is also an important component of skin composition. Elastin contains only 5% in the skin, but it is the key to producing elastic fibers and supporting collagen. Elastin molecules can be curled arbitrarily. Under the pull of an external force, the curled elastin molecules stretch and stretch. After removing the external force, the elastin molecules return to a curled state, just like a spring. Human elastin is mainly synthesized from the late embryo to the early neonatal period, and almost no new elastin is produced in the adult stage. Collagen, which accounts for 70% of the skin, determines the suppleness and fullness of the skin, while elastic fibers determine the firmness and elasticity of the skin. The same saccharification and photoaging processes will also cause the elastic fibers to undergo qualitative changes and lose their original elasticity. Elastase is an enzyme that can break down elastin in connective tissue. Decreased elastin can cause signs of aging such as wrinkles and sagging. Therefore, how to reduce the reduction and destruction of elastin is an anti-aging, anti-wrinkle, and maintaining skin health and firmness, which is a topic worthy of attention.

綜合上所論,補充膠原蛋白或是提升細胞的膠原蛋白生成能力,以及抑制彈性蛋白分解是預防或減緩皮膚老化之重要方法,更可以防止因為醣化的蛋白質累積而衍生的相關疾病。目前市面上存在膠原蛋白相關之產品,皆以直接補充膠原蛋白為主要功能,然而,膠原蛋白的分子大,塗抹方式幾乎無法使膠原蛋白穿透皮膚的角質層到達其所作用之真皮層皮膚纖維母細胞;若是以注射的方式直接補充膠原蛋白,雖然可立即減少皮膚的細紋,但該注射進入體內的膠原蛋白易被體內的酵素分解,需定期的施打,過程繁複且成本高,而注射膠原蛋白可能產生的免疫排斥反應更是一大風險。若是以食用富含膠原蛋白的食品來補充膠原蛋白,膠原蛋白進到腸胃後,經由消化液切斷成小分子,最後分解成胺基酸。身體固然會利用這些胺基酸合成蛋白質,但不限於膠原蛋白,因此實際補充膠原蛋白的效果有限。另一方面,彈性蛋白之產品,塗抹方式同樣無法補充替代減少的彈性蛋白或纖維;研究發現體內的彈性蛋白幾乎無法再生,現有尚在研究階段的體外培養技術,產生彈性蛋白結構後再植入體內,不過尚未技術成熟。因此抑制彈性蛋白酶活性成為少數能避免彈性蛋白減少導致老化、皮膚下垂的重要途徑。In summary, supplementing collagen or enhancing the collagen production capacity of cells, and inhibiting the degradation of elastin are important methods to prevent or slow skin aging, and can prevent related diseases derived from the accumulation of glycated proteins. At present, there are collagen-related products on the market, and the main function is to directly supplement collagen. However, the large molecular weight of collagen makes it difficult to apply collagen through the stratum corneum of the skin to the skin fibers of the dermis. Mother cells; if collagen is directly replenished by injection, although the fine lines of the skin can be reduced immediately, the collagen injected into the body is easily broken down by enzymes in the body, which requires regular application. The process is complicated and costly, and The immune rejection that can be caused by collagen injection is a big risk. If collagen is supplemented by eating foods rich in collagen, collagen enters the stomach and intestines, is cut into small molecules through digestive juices, and finally breaks down into amino acids. Although the body uses these amino acids to synthesize proteins, it is not limited to collagen, so the actual effect of collagen supplementation is limited. On the other hand, elastin products can not be replaced by the same method of elastin or fiber; the study found that the elastin in the body can hardly be regenerated, and the existing in vitro culture technology that is still in the research stage produces elastin structure and then implants it. In vivo, but not yet technically mature. Therefore, inhibition of elastase activity has become one of the few important ways to avoid elastin reduction and skin sag.

本發明主要特徵在於該萃取物經萃取並純化後取得之組成物可使用於抗氧化、美白或抗皮膚老化之應用。The main feature of the invention is that the composition obtained after the extract is extracted and purified can be used for anti-oxidation, whitening or anti-aging of the skin.

本發明另一主要特徵在於其包含以下步驟:取台灣藜殼,依序進行酒精萃取、過濾及乾燥後產生初步萃取物;前述初步萃取物可選擇進行進一步純化或區分步驟使該初步萃取物之不同性質的成份分開或直接使用於產品。Another main feature of the present invention is that it comprises the following steps: taking Taiwan quinoa shell, sequentially performing alcohol extraction, filtering, and drying to produce a preliminary extract; the preliminary extract may be further purified or differentiated to make the preliminary extract Ingredients with different properties are used separately or directly in the product.

取台灣藜外殼,進行清潔,乾燥後以物理方法研磨為粉末;取台灣藜殼粉末放入酒精中進行濃縮,得到一初步萃取物。Take the Taiwan quinoa shell, clean it, dry it and grind it into powder physically; take the Taiwan quinoa shell powder into alcohol and concentrate to obtain a preliminary extract.

更佳的,取台灣藜殼粉末加入酒精濃縮後,將初步萃取物回溶與水中,先加入有機溶劑進行分層萃取數次,以去除油相中的干擾物;其後再取水相萃取液濃縮,以減少可能留在萃取物中的有機溶劑,得到一純化之萃取物。可直接利用該純化萃取之台灣藜殼酒精萃取物(EEDH),或依據需求接續層析法進行區分,依據需求使用不同條件之區分物,其中區分方法可為,不限於層析法。其中該分層萃取之有機溶劑可為醚、二氯甲烷、氯仿、四氯化碳、苯、異戊醇、正丁醇、正戊烷及正己烷等。More preferably, after taking Taiwan quinoa powder and adding alcohol to concentrate, the initial extract is dissolved in water, and the organic solvent is added for layered extraction several times to remove the interferences in the oil phase; then the aqueous phase extract is taken. Concentrate to reduce the organic solvents that may remain in the extract to obtain a purified extract. The purified and extracted Taiwan quinoa alcohol extract (EEDH) can be used directly, or the chromatography can be differentiated according to the requirements, and the different conditions can be used according to the requirements. The method of differentiation can be, but not limited to, chromatography. The organic solvent for the layered extraction may be ether, dichloromethane, chloroform, carbon tetrachloride, benzene, isoamyl alcohol, n-butanol, n-pentane, and n-hexane.

較佳的實施例如後,取台灣藜粉末,溶於95%酒精後進行四倍濃縮,得到初步萃取液;過濾初步萃取液並去除酒精後,將所的萃取物以二次水回溶;再加入正己烷進行分層萃取數次,以去除油相物質。取前述分層萃取之水相萃取液(EEDH)進行管柱色層分析,取得水區分物(EEDH-W)、50%酒精區分物(EEDH-50)及95%酒精區分物(EEDH-95),與未管柱層析之台灣藜殼酒精萃取物(EEDH)進行後續試驗及分析,結果如圖2-1For a preferred embodiment, take Taiwan quinoa powder, dissolve it in 95% alcohol, and concentrate it four times to obtain a preliminary extract. After filtering the preliminary extract and removing alcohol, re-dissolve the extract with secondary water; N-hexane was added for layered extraction several times to remove oil phase material. Take the aforementioned phase-extracted aqueous phase extraction solution (EEDH) for column chromatography and obtain the water (EEDH-W), 50% alcohol (EEDH-50), and 95% alcohol (EEDH-95) ), And subsequent experiments and analysis with Taiwan quinoa alcohol extract (EEDH) without column chromatography, the results are shown in Figure 2-1

圖2-1為胞外彈性蛋白酶活性抑制試驗,以台灣藜殼95%酒精區分物分物進行試驗,由結果得知台灣藜殼95%酒精區分物在0.25-4.0 mg/mL的濃度下,有顯著具有劑量效應地抑制彈性蛋白酶活性的能力,IC50約為1.0 mg/mL,其在4.0 mg/mL之抑制效果與0.66 mg/mL (3.75 mM)的抗壞血酸相當(抑制率約為95%),顯示台灣藜殼95%酒精區分物具有開發美白及抗皺組成物的潛力。Figure 2-1 is an extracellular elastase activity inhibition test. The test was performed with the 95% alcohol fraction of Taiwan quinoa, and the results showed that the 95% alcohol fraction of Taiwan quinoa was at a concentration of 0.25-4.0 mg / mL. It has significant ability to inhibit elastase activity with a dose effect. IC50 is about 1.0 mg / mL, and its inhibitory effect at 4.0 mg / mL is equivalent to 0.66 mg / mL (3.75 mM) ascorbic acid (inhibition rate is about 95%). It shows that the 95% alcohol fraction of Taiwan quinoa has the potential to develop whitening and anti-wrinkle compositions.

由圖2-2研究結果發現,在以紫外光(UVB)誘導皮膚纖維母細胞(HaCat)中系統中,發現在1000 μg/mL之濃度下,台灣藜殼酒精萃取物(EEDH)、50%酒精區分物(EEDH-50)及95%酒精區分物(EEDH-95)之彈性蛋白分解酶活性抑制能力均小於40%,而台灣藜殼酒精萃取物之水區分物(EEDH-W)的抑制能力最佳,且呈顯著的劑量效應,約有81%之抑制能力,IC50約為500 μg/mL。From the study results in Figure 2-2, it was found that in the system that induced skin fibroblasts (HaCat) with ultraviolet light (UVB), at a concentration of 1000 μg / mL, it was found that Taiwan quinoa alcohol extract (EEDH), 50% Ethanol classifiers (EEDH-50) and 95% alcohol classifiers (EEDH-95) have less than 40% inhibition of elastin degrading enzyme activity, while the water classifier (EEDH-W) of Taiwan quinoa alcohol extract inhibits It has the best ability and has a significant dose effect. It has an inhibitory capacity of about 81% and an IC50 of about 500 μg / mL.

培養黑色素瘤細胞(B16F10)施用不同試劑測試黑色素抑制能力,以評估本發明美白能力,台灣藜殼酒精萃取物及其區分物,以1 μMα-黑色素細胞刺激素(α-MSH)誘導黑色素瘤細胞形成黑色素能力的影響。試驗結果如圖3,顯微鏡放大倍率100X。Culture melanoma cells (B16F10) to test the melanin inhibition ability by applying different reagents to evaluate the whitening ability of the present invention, Taiwan quinoa alcohol extract and its differentiation, and induce melanoma cells with 1 μM α-melanocyte stimulating hormone (α-MSH) Influence of the ability to form melanin. The test results are shown in Figure 3 with a microscope magnification of 100X.

由圖3結果顯示,α-黑色素細胞刺激素與黑色素瘤細胞培養六天,顯著促進黑色素形成,200 μM之麴酸(Kojic acid)則有顯著抑制黑色素形成的趨勢。台灣藜殼酒萃物(EEDH)在50-200μg/mL之濃度下,黑色素形成量顯著下降,而其區分物50%酒精區分物(EEDH-50)及95%酒精區分物(EEDH-95)亦呈顯著下降趨勢。The results in Figure 3 show that culture of α-melanocyte stimulating hormone and melanoma cells for six days significantly promoted melanin formation, and 200 μM Kojic acid had a significant tendency to inhibit melanin formation. Taiwan quinoa wine extract (EEDH) at a concentration of 50-200 μg / mL, the amount of melanin formation significantly decreased, and its distinguishing 50% alcohol (EEDH-50) and 95% alcohol (EEDH-95) There is also a significant downward trend.

依據台灣藜殼酒精萃取物及其區分物之濃度分為50、100、200、500及1000 ug/mL五組對黑色素細胞的細胞存活率測試該萃取物安全性,由結果圖4可知,台灣藜殼酒萃物(EEDH)、水區分物(EEDH-W)及50%酒精區分物(EEDH-50) 在200 μg/mL均未有顯著的細胞毒性,細胞存活率>85%,因此三種樣品在後續試驗選擇以200 μg/mL以下濃度進行,而95%酒精區分物(EEDH-95)在200 μg/mL即有非常顯著的細胞毒性,故選擇100 μg/mL以下濃度,進行抑制黑色素瘤細胞之酪胺酸酶活性及黑色素形成試驗。Based on the concentration of the Taiwan quinoa alcohol extract and its differentiators, it was divided into five groups: 50, 100, 200, 500, and 1000 ug / mL to test the cell survival rate of melanocytes. The safety of the extract is shown in Figure 4, which shows that Taiwan Quinoa wine extract (EEDH), water (EEDH-W) and 50% alcohol (EEDH-50) have no significant cytotoxicity at 200 μg / mL, and the cell survival rate is> 85%. In the subsequent experiments, the sample was selected to be under 200 μg / mL, and the 95% alcohol fraction (EEDH-95) had very significant cytotoxicity at 200 μg / mL. Therefore, the concentration below 100 μg / mL was selected to inhibit melanin Tumor cells for tyrosinase activity and melanin formation test.

接著進一步分析台灣藜殼酒精萃取物及其區分物對1 μMα-黑色素細胞刺激素誘導黑色素瘤細胞之酪胺酸酶活性及黑色素形成量的影響,圖5、6結果顯示,台灣藜殼酒萃物(EEDH)在200 μg/mL之濃度下之抑制酪胺酸酶活性及黑色素形成能力分別約為60%及50%,三個區分物皆有顯著的抑制酪胺酸酶活性及黑色素形成能力,其效果均優於200 μM之麴酸。其中以50%酒精區分物(EEDH-50)之抑制效果為最佳,呈現明顯的劑量效應,在200 μg/mL之濃度下之抑制酪胺酸酶活性及黑色素形成能力均可達分別約為84%及86%之抑制效果。Next, the effects of alcohol extracts from Taiwan quinoa and their differentiators on the tyrosinase activity and melanin formation of melanoma cells induced by 1 μM α-melanocyte stimulating hormone were further analyzed. Figures 5 and 6 show that Taiwan quinoa extract (EEDH) at a concentration of 200 μg / mL inhibits tyrosinase activity and melanin formation ability of approximately 60% and 50%, respectively. All three distinguishers have significant inhibition of tyrosinase activity and melanin formation ability. , Its effect is better than 200 μM of osmic acid. Among them, the inhibitory effect of the 50% alcohol classifier (EEDH-50) is the best, showing a significant dose effect. The inhibition of tyrosinase activity and melanin formation ability at a concentration of 200 μg / mL can reach about 84% and 86% inhibition effect.

進一步分析台灣藜殼酒精萃取物及其區分物之抗老化及抗醣化能力,分別以清除自由基能力及最終醣化蛋白(AGEs)形成能力的影響兩項試驗進行台灣藜殼酒精萃取物及其區分物之抗氧化力及抗醣化能力評估。To further analyze the anti-aging and anti-glycation ability of Taiwan quinoa alcohol extract and its fractions, the effects of free radical scavenging ability and final glycosylated protein (AGEs) formation ability were tested in two experiments. Evaluation of the antioxidant power and anti-glycation ability of the material.

清除自由基能力,以供氫能力測定,係利用1,1-二苯基-2-三硝基苯肼(簡稱為DPPH)自由基清除能力(scavenging effect)表示。取4 ml萃取物,加1 mL新鮮配製的1.0×10-4 mM DPPH之甲醇溶液,均勻混合,靜置30分鐘後,檢測517 nm 之吸光值,結果如圖7。The ability to scavenge free radicals, as measured by the hydrogen supply capacity, is expressed by the scavenging effect of 1,1-diphenyl-2-trinitrophenylhydrazine (abbreviated as DPPH). Take 4 ml of the extract, add 1 mL of freshly prepared methanol solution of 1.0 × 10-4 mM DPPH, and mix uniformly. After standing for 30 minutes, check the absorbance at 517 nm. The results are shown in Figure 7.

由圖7結果顯示,台灣藜殼酒精萃取物及台灣藜殼酒精萃取物之水區分物、50%酒精區分物均有相當良好的清除DPPH自由基能力,除了95%酒精區分物外,均呈現顯著的濃度抑制效應,其中以50%酒精區分物(EEDH-50)的效果最佳(IC50約等於1.5 mg/mL),其次為台灣藜殼酒精萃取物之水區分物(EEDH-W)、台灣藜殼酒精萃取物(EEDH),在2 mg/mL的濃度下,三者之DPPH清除率依次為66.7、45.6及33.5%。The results shown in Figure 7 show that the water and 50% alcohol fractions of Taiwan quinoa alcohol extract and Taiwan quinoa alcohol extract have a very good ability to scavenge DPPH free radicals, except for the 95% alcohol fraction, both present Significant concentration inhibition effect. Among them, the 50% alcohol fraction (EEDH-50) has the best effect (IC50 is about 1.5 mg / mL), followed by the water fraction (EEDH-W), At a concentration of 2 mg / mL, the Taiwanese quinoa alcohol extract (EEDH) had DPPH clearance rates of 66.7, 45.6, and 33.5% in order.

台灣藜殼酒精萃取物及其區分物對最終醣化蛋白形成能力的影響,將10μL萃取物加入740 μL之50mg/mL 牛血清白蛋白BSA (溶於內含0.05% 疊氮化鈉之磷酸鹽緩衝生理鹽水)及250μL之3M 葡萄糖混和均勻,於37℃反應3週後,利用螢光偵測器在激發波長330 nm、放射波長410 nm之條件下,測得螢光值,結果如圖8。The effect of Taiwan quinoa shell alcohol extract and its fraction on the final glycosylated protein formation ability, 10 μL of the extract was added to 740 μL of 50 mg / mL bovine serum albumin BSA (dissolved in phosphate buffer containing 0.05% sodium azide Normal saline) and 250 μL of 3M glucose were mixed uniformly. After reacting at 37 ° C for 3 weeks, the fluorescence value was measured using a fluorescence detector at an excitation wavelength of 330 nm and an emission wavelength of 410 nm. The results are shown in FIG. 8.

由圖8結果可知,台灣藜殼酒精萃取物在1000μg/mL之濃度下僅約有30%之抑制最終醣化蛋白形成的能力,區分物中以50%酒精區分物(EEDH-50)表現能力最佳,約有65%之抑制效果,其在500μg/mL之抑制最終醣化蛋白形成能力與1 mM之已知醣化抑制劑氨基胍(Aminoguanidine)相當。但其餘區分物則未有顯著抑制最終醣化蛋白形成能力。From the results in Figure 8, it can be seen that the alcohol extract of Taiwan quinoa has only about 30% ability to inhibit the formation of the final glycosylated protein at a concentration of 1000 μg / mL, and the 50% alcohol classifier (EEDH-50) has the best performance. The inhibitory effect is about 65%, and its ability to inhibit the final glycosylated protein formation at 500 μg / mL is equivalent to 1 mM of the known glycosylation inhibitor Aminoguanidine. However, the other differentiations did not significantly inhibit the final glycated protein formation ability.

綜合上述結果,台灣藜殼酒精萃取物(EEDH)在清除自由基、抑制糖化能力、胞外酪胺酸酶及胞外彈性蛋白分解酶活性評估能力中,均具有顯著的抑制效果;且經過管柱層析分離後所得區分物在各種抗氧化、美白及抗老化能力評估中,均顯著提升。其中以50%酒精區分物(EEDH-50)之抗氧化抗醣化及美白能力為最佳;但在胞外及皮膚細胞不同模式系統中分別以95%酒精區分物(EEDH-95)及水區分物(EEDH-W)為最佳。後續利用之產品可依據用途、功效訴求,選擇適合之區間區分物作為原料。Based on the above results, Taiwan quinoa alcohol extract (EEDH) has significant inhibitory effects in scavenging free radicals, inhibiting saccharification, and evaluating the activity of extracellular tyrosinase and extracellular elastin degrading enzymes. The fractions obtained after column chromatography were significantly improved in various evaluations of antioxidant, whitening and anti-aging capabilities. Among them, the 50% alcohol classifier (EEDH-50) has the best antioxidant and anti-glycation and whitening ability; however, it is distinguished by 95% alcohol classifier (EEDH-95) and water in different models of extracellular and skin cell systems. (EEDH-W) is the best. Subsequent products can be selected as suitable raw materials according to the use and efficacy requirements.

Claims (8)

一種台灣藜殼酒精萃取物,該萃取物經萃取並純化後取得之組成物可使用於抗氧化、美白或抗皮膚老化之應用。A Taiwan quinoa alcohol extract, the composition obtained after extraction and purification can be used for anti-oxidation, whitening or anti-aging applications. 如申請專利範圍第1項所述台灣藜殼酒精萃取物,其中該組成物係可應用於外用擦劑、外用醫藥品、外用保養品或化妝品之始用原料。As described in claim 1 of the scope of patent application, the alcohol extract of Chenopodium taiwanensis, wherein the composition is applicable to the raw materials for external wipes, external medicines, external care products or cosmetics. 如申請專利範圍第1項所述台灣藜殼酒精萃取物,其中該組成物係可應用於食品或醫療保健品之始用原料。As described in item 1 of the patent application scope, the Taiwan quinoa alcohol extract, wherein the composition is applicable to the raw materials of food or medical care products. 如申請專利範圍第1項所述台灣藜殼酒精萃取物,其中該萃取係取台灣藜殼,依序進行酒精萃取、過濾及乾燥後產生初步萃取物。As described in the first patent application scope, the Taiwan quinoa shell alcohol extract, wherein the extraction is from Taiwan quinoa shell, followed by alcohol extraction, filtration and drying to produce a preliminary extract. 如申請專利範圍第1項所述台灣藜殼酒精萃取物,其中該純化係萃取後進一步純化或區分步驟使該初步萃取物之不同性質的成份分開或直接使用於產品。As described in item 1 of the patent application scope, the Taiwan quinoa alcoholic extract, wherein the purification is a step of further purification or differentiation after extraction, so that components of different properties of the preliminary extract are separated or used directly in the product. 一種台灣藜殼酒精萃取物之萃取方法,其包含以下步驟: 萃取步驟:取台灣藜殼,依序進行酒精萃取、過濾及乾燥後產生初步萃取物。 純化步驟:前述初步萃取物可選擇進行進一步純化或區分步驟使該初步萃取物之不同性質的成份分開或直接使用於產品。A method for extracting Taiwanese quinoa shell alcohol extract includes the following steps: Extraction step: taking Taiwan quinoa shell, sequentially performing alcohol extraction, filtering and drying to produce a preliminary extract. Purification step: The aforementioned preliminary extract can be optionally subjected to further purification or differentiation steps to separate or directly use different components of the preliminary extract from the product. 如申請專利範圍第4項所述台灣藜殼酒精萃取物萃取方法,其中該純化步驟係透過分層萃取將不需要之干擾物分離。The method for extracting alcohol extract from Taiwan quinoa, as described in item 4 of the scope of patent application, wherein the purification step is to separate unwanted interferences through layered extraction. 如申請專利範圍第4項所述之台灣藜殼酒精萃取物之萃取方法,其中該區分步驟係透過層析法將有效成份分離並濃縮,該管柱層析之層析液係酒精.其區分濃度為50-95%。The method for extracting the alcohol extract of Taiwan quinoa, as described in item 4 of the scope of patent application, wherein the distinguishing step is separating and concentrating the effective ingredients by chromatography, and the chromatography liquid of the column chromatography is alcohol. Its distinguishing concentration is 50-95%.
TW106128655A 2017-08-23 2017-08-23 Taiwan clam shell extracting substance with whitening and anti-aging function and its extraction and separation method TW201912177A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW106128655A TW201912177A (en) 2017-08-23 2017-08-23 Taiwan clam shell extracting substance with whitening and anti-aging function and its extraction and separation method
CN201810340106.4A CN109419830A (en) 2017-08-23 2018-04-16 Taiwan Chenopodium quinoa shell extract with whitening and antiaging effects, and its extraction and separation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW106128655A TW201912177A (en) 2017-08-23 2017-08-23 Taiwan clam shell extracting substance with whitening and anti-aging function and its extraction and separation method

Publications (1)

Publication Number Publication Date
TW201912177A true TW201912177A (en) 2019-04-01

Family

ID=65514443

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106128655A TW201912177A (en) 2017-08-23 2017-08-23 Taiwan clam shell extracting substance with whitening and anti-aging function and its extraction and separation method

Country Status (2)

Country Link
CN (1) CN109419830A (en)
TW (1) TW201912177A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI754327B (en) * 2019-07-19 2022-02-01 大江生醫股份有限公司 Lactobacillus paracasei and an use of lactobacillus paracasei in preparing compositions for the removal of advanced glycation end products
WO2022141182A1 (en) * 2020-12-30 2022-07-07 财团法人医药工业技术发展中心 Pharmaceutical composition for treating alcoholic fatty liver and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI516280B (en) * 2014-03-20 2016-01-11 大江生醫股份有限公司 Use of chenopodium formosanum extract for manufacture of composition for enhancing secretion of collagen and preventing cutaneous aging
TWI625125B (en) * 2016-09-29 2018-06-01 大葉大學 Preparing method of chenopodium formosanum extracts and dressing composition
TWM539335U (en) * 2016-11-30 2017-04-11 大葉大學 Patch structure with Chenopodium formosanum extract dressing

Also Published As

Publication number Publication date
CN109419830A (en) 2019-03-05

Similar Documents

Publication Publication Date Title
CN107822948B (en) Composition with after-sun repair, oxidation resistance and whitening effects and preparation method thereof
US20080206175A1 (en) Composition for Skin Whitening and Wrinkle Improvement Comprising Vaccinium Uliginosum Extract and Method for Preparation Thereof
CN107557421B (en) Method for extracting effective components from ganoderma lucidum
US9089576B2 (en) Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency or oxidative stress or skin ageing or dry skin
CN110574927B (en) Anti-saccharification composition and preparation method thereof
EP1945046A1 (en) Method of obtaining a plant extract from pome fruit, plant extract thus obtained and use of same
JP2008137998A (en) Skin ameliorating agent and oral composition for beauty and health
KR101861043B1 (en) Composition for Improving Skin Wrinkles Using an Extract of Penthorum chinense
Thent et al. Effect of Piper sarmentosum extract on the cardiovascular system of diabetic sprague-dawley rats: electron microscopic study
JP2009046465A (en) Skin cosmetic and food/drink
CN112641702A (en) Wrinkle-removing and anti-aging composition and preparation method and application thereof
WO2008067315A1 (en) Therapeutic composition from goji (lycium barbarum l.), methods of making and using
CN106722999B (en) Collagen peptide preparation method, low-sugar collagen beauty cake containing collagen peptide preparation method and preparation method
CN111265441A (en) Composition capable of enhancing skin night repair and regeneration capacity and application thereof
TW201912177A (en) Taiwan clam shell extracting substance with whitening and anti-aging function and its extraction and separation method
JP2016175861A (en) Epidermal turnover accelerator, skin collagen production accelerator, and skin cosmetic
CN110495610A (en) A kind of collagen composition and preparation method thereof
JP2003081850A (en) Skin cosmetic
JP4672269B2 (en) Anti-aging agent, platelet aggregation inhibitor, antioxidant, antiallergic agent, skin cosmetics and food and drink
KR101517836B1 (en) A composition for the treatment of atherosclerosis comprising the red ginseng complex
JP2019147824A (en) Kaempferia parviflora-containing compositions
KR20190004241A (en) Composition for Improving Skin Wrinkles or Moisturizing Skin Using an Extract of Immature Citrus Fruit
KR100991309B1 (en) Chinese Composition for Hair Protection and Hair Growth-Promotion and Methods for Preparing the Same
CN113576970A (en) Anti-aging plant extract composition and preparation and application thereof
KR20110139016A (en) Process of manufacturing method of high-content ginsenoside rg3 using by acid treatment and far-infrared radiation dry